Dr. Falcone is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
215 E 68th St
Ofc 8
New York, NY 10065Phone+1 212-288-2869Fax+1 646-304-6219
Summary
- Dr. John Falcone is an endocrinologist in New York, NY and is affiliated with New York-Presbyterian Hospital and Weill Cornell Medicine. He received his medical degree from Drexel University College of Medicine. He completed his residency in Internal Medicine and fellowship in Endocrinology at New York-Presbyterian/Weill Cornell and Memorial Sloan Kettering Cancer Center. He has conducted clinical research on the application of precision medicine in diabetes and other metabolic diseases. Dr. Falcone specializes in diabetes, weight management, and conditions affecting the thyroid, adrenals, pituitary, bones, and both male and female hormones .
Education & Training
- Weill Cornell MedicineResearch Fellowship in Diabetes, Dyslipidemia, and Metabolic Disease, 2021 - 2022
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2019 - 2021
- New York Presbyterian Hospital (Cornell Campus)Residency, Endocrinology, Diabetes, and Metabolism, 2016 - 2019
- Drexel University College of MedicineClass of 2016
Certifications & Licensure
- NY State Medical License 2021 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
- AOA Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 60 citationsDeveloping dietary interventions as therapy for cancer.Samuel R Taylor, John N Falcone, Lewis C Cantley, Marcus D Goncalves
Nature Reviews. Cancer. 2022-08-01 - 11 citationsTreating Alpelisib-Induced Hyperglycemia with Very Low Carbohydrate Diets and Sodium-Glucose Co-Transporter 2 Inhibitors: A Case SeriesTahj Blow, Parker N. Hyde, John N. Falcone, Aaron B. Neinstein, Neil Vasan
Integrative Cancer Therapies. 2021-07-14 - 29 citationsRadioactive Iodine-Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival.Laura Boucai, John N. Falcone, Jenny Ukena, Catherine C. Coombs, Ahmet Zehir
The Journal of Clinical Endocrinology and Metabolism. 2018-11-01
Journal Articles
- . Developing dietary interventions as therapy for cancerTaylor, S, Falcone JN, Cantley LC, Goncalves MD, Nature Reviews Cancer, 5/25/2022
- Autophagy levels are elevated in Barrett’s esophagus and promote cell survival from acid and oxidative stressKong J, Whelan K, Dang B, Caro-Monroi A, Soroush A, Falcone J, Amaravadi R, Rustgi A, Ginsberg G, Falk G, Nakagawa H, Lynch J, Molecular Carcinogenesis, 11/2016
- O-GlycNAcylation regulates cancer metabolism and survival stress signaling via upregulation of HIF-1 pathwayFerrer CM, Lynch TP, Sodi V, Falcone JN, Schwab L, Peacock D, Vocadlo DJ, Seagroves TN, Reginato MJ, Molecular Cell, 6/2014
Books/Book Chapters
Press Mentions
- Networking for SuccessMay 5th, 2023
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: